Aura Biosciences, Inc.AURANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank20
3Y CAGR-40.3%
5Y CAGR-0.5%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-40.3%/yr
Annual compound
5Y CAGR
-0.5%/yr
Recent deceleration
Percentile
P20
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$31.69M-22.8%
2023$41.06M-66.2%
2022$121.58M-18.4%
2021$149.06M+757.0%
2020$17.39M-46.4%
2019$32.47M-